If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: 4D Pharma on their Merger & Intention to seek NASDAQ Listing plus Chris Bailey on 4 Large Caps and Chris Bailey on 4 Large Caps
Duncan Peyton, Chief Executive Officer of 4D Pharma #DDDD explains the reasons behind their merger and intention to seek a NASDAQ listing.
Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx®, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.
Chris Bailey founder of Financial Orbit covers news from the following companies:
GSK #GSK
Unilever #ULVR
International Consolidated Airlines #IAG
RELX #REL
(Interview starts at 11 minutes 29 seconds)